These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36944974)

  • 1. Identification of thrombotic biomarkers in orthopedic surgery patients by plasma proteomics.
    Liu CQ; Gao YJ; Lin GX; Liang JZ; Li YF; Wang YC; Chen WY; Chen WJ
    J Orthop Surg Res; 2023 Mar; 18(1):222. PubMed ID: 36944974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.
    Bruzelius M; Iglesias MJ; Hong MG; Sanchez-Rivera L; Gyorgy B; Souto JC; Frånberg M; Fredolini C; Strawbridge RJ; Holmström M; Hamsten A; Uhlén M; Silveira A; Soria JM; Smadja DM; Butler LM; Schwenk JM; Morange PE; Trégouët DA; Odeberg J
    Blood; 2016 Dec; 128(23):e59-e66. PubMed ID: 27742707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients.
    Fu Y; Liu Y; Chen S; Jin Y; Jiang H
    Medicine (Baltimore); 2018 Nov; 97(47):e13232. PubMed ID: 30461624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications.
    Calabrò P; Gragnano F; Golia E; Grove EL
    Semin Thromb Hemost; 2018 Apr; 44(3):249-260. PubMed ID: 28898897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.
    Karakaya B; Tombak A; Serin MS; Tiftik N
    Hematology; 2016 Jun; 21(5):295-9. PubMed ID: 26872106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of gingival crevicular fluids to identify novel biomarkers of gingival recession in orthodontic patients.
    Pei F; Wang M; Wang Y; Pan X; Cen X; Huang X; Jin Y; Zhao Z
    J Proteomics; 2022 Aug; 266():104647. PubMed ID: 35779762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
    Sabater-Lleal M; Huffman JE; de Vries PS; Marten J; Mastrangelo MA; Song C; Pankratz N; Ward-Caviness CK; Yanek LR; Trompet S; Delgado GE; Guo X; Bartz TM; Martinez-Perez A; Germain M; de Haan HG; Ozel AB; Polasek O; Smith AV; Eicher JD; Reiner AP; Tang W; Davies NM; Stott DJ; Rotter JI; Tofler GH; Boerwinkle E; de Maat MPM; Kleber ME; Welsh P; Brody JA; Chen MH; Vaidya D; Soria JM; Suchon P; van Hylckama Vlieg A; Desch KC; Kolcic I; Joshi PK; Launer LJ; Harris TB; Campbell H; Rudan I; Becker DM; Li JZ; Rivadeneira F; Uitterlinden AG; Hofman A; Franco OH; Cushman M; Psaty BM; Morange PE; McKnight B; Chong MR; Fernandez-Cadenas I; Rosand J; Lindgren A; ; Gudnason V; Wilson JF; Hayward C; Ginsburg D; Fornage M; Rosendaal FR; Souto JC; Becker LC; Jenny NS; März W; Jukema JW; Dehghan A; Trégouët DA; Morrison AC; Johnson AD; O'Donnell CJ; Strachan DP; Lowenstein CJ; Smith NL
    Circulation; 2019 Jan; 139(5):620-635. PubMed ID: 30586737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The α2-Plasmin Inhibitor-Plasmin Complex is a Potential Biomarker of Venous Thromboembolism in Orthopedic Trauma Patients.
    Guo X; Tao H; Li D; Li Y
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis.
    Lazzari MA; Sanchez-Luceros A; Woods AI; Alberto MF; Meschengieser SS
    Hematology; 2012 Apr; 17 Suppl 1():S150-2. PubMed ID: 22507806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting prothrombotic state implied by changes of plasma von Willebrand factor parameters after radical prostatectomy for prostate malignancy.
    Harsfalvi J; Molnar Z; Csanyi MC; Domjan I; Flasko T; Kaposi A; Benyo M
    Urol Oncol; 2020 Apr; 38(4):191-197. PubMed ID: 31711834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism.
    Edvardsen MS; Hansen ES; Hindberg K; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood; 2021 Dec; 138(22):2269-2277. PubMed ID: 34161566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
    Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.
    Edvardsen MS; Hindberg K; Hansen ES; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood Adv; 2021 Jan; 5(1):224-232. PubMed ID: 33570640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.
    van Loon JE; Leebeek FW; Deckers JW; Dippel DW; Poldermans D; Strachan DP; Tang W; O'Donnell CJ; Smith NL; de Maat MP
    Circ Cardiovasc Genet; 2010 Dec; 3(6):507-12. PubMed ID: 21156930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ADAMTS13 activity in patients with venous thromboembolism.
    Mazetto BM; Orsi FL; Barnabé A; De Paula EV; Flores-Nascimento MC; Annichino-Bizzacchi JM
    Thromb Res; 2012 Dec; 130(6):889-93. PubMed ID: 23031329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
    Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
    Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
    Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
    J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
    Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.